ID: ALA4783224

Max Phase: Preclinical

Molecular Formula: C33H34N6O6

Molecular Weight: 610.67

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCOc1nc2ccc(C(=O)OC(C)OC(=O)OC3CCCCC3)cc2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

Standard InChI:  InChI=1S/C33H34N6O6/c1-3-42-32-34-28-18-17-24(31(40)43-21(2)44-33(41)45-25-9-5-4-6-10-25)19-29(28)39(32)20-22-13-15-23(16-14-22)26-11-7-8-12-27(26)30-35-37-38-36-30/h7-8,11-19,21,25H,3-6,9-10,20H2,1-2H3,(H,35,36,37,38)

Standard InChI Key:  GTAZMTLCKUIJBL-UHFFFAOYSA-N

Associated Targets(Human)

NEDD8-activating enzyme E1 regulatory subunit 121 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

A549 127892 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 610.67Molecular Weight (Monoisotopic): 610.2540AlogP: 6.32#Rotatable Bonds: 10
Polar Surface Area: 143.34Molecular Species: ACIDHBA: 11HBD: 1
#RO5 Violations: 3HBA (Lipinski): 12HBD (Lipinski): 1#RO5 Violations (Lipinski): 3
CX Acidic pKa: 4.23CX Basic pKa: 2.19CX LogP: 7.53CX LogD: 5.93
Aromatic Rings: 5Heavy Atoms: 45QED Weighted: 0.14Np Likeness Score: -0.82

References

1. Chen X,Yang X,Mao F,Wei J,Xu Y,Li B,Zhu J,Ni S,Jia L,Li J.  (2021)  Development of novel benzimidazole-derived neddylation inhibitors for suppressing tumor growth invitro and invivo.,  210  [PMID:33129593] [10.1016/j.ejmech.2020.112964]

Source